Literature DB >> 170527

Oestrogen-responsive human breast cancer in long term tissue culture.

M E Lippman, G Bolan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170527     DOI: 10.1038/256592a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  63 in total

1.  Estrogen mitogenic action. III. is phenol red a "red herring"?

Authors:  J E Moreno-Cuevas; D A Sirbasku
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

2.  The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum.

Authors:  Amin Esfahani; Cyril W C Kendall; Balachandran Bashyam; Michael C Archer; David J A Jenkins
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-10-07       Impact factor: 2.416

3.  The effect of adjuvant therapy with or without tamoxifen on the endocrine function of patients with breast cancer.

Authors:  T Yasumura; T Akami; M Mitsuo; T Oka; K Naitoh; T Yamamoto; H Honjyo; H Okada
Journal:  Jpn J Surg       Date:  1990-07

Review 4.  Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

5.  A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?

Authors:  Daniel F Hayes; Vered Stearns; James Rae; David Flockhart
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

6.  c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Authors:  O W Prall; E M Rogan; E A Musgrove; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

Review 7.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

8.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

Authors:  E A Musgrove; J A Hamilton; C S Lee; K J Sweeney; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Effect of the anti-oestrogen tamoxifen on the development of renal cortical necrosis induced by oestrone + vasopressin administration in rats.

Authors:  J Kocsis; G Karácsony; S Karcsú; F A László
Journal:  Br J Exp Pathol       Date:  1988-04

Review 10.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.